Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD

Back Bay Life Science Report

In this episode of Back Bay’s industry podcast, The Life Science Report, Dr. Peter Bak is joined by Mike Bogetofte Barnkob, a doctor with the Department of Clinical Immunology at Odense University Hospital in Denmark and a research fellow at the University of Southern Denmark, to discuss current perspectives—clinical, scientific and manufacturing—on the cell therapy space.

Dr. Barnkob’s expertise spans basic and clinical immunology, with a particular interest in advanced cellular modalities, such as chimeric antigen or CAR T-cells. He studied at the Massachusetts Institute of Technology, in Back Bay’s hometown, and completed his PhD at Oxford University.

Topics in this podcast include:

• The current clinical and academic uses of CAR T-cells and where they are headed in the near-term
• How cellular therapies factor into a robust and thriving public healthcare-based system
• Ongoing questions of pricing and reimbursement
• Challenges and approval processes in getting these "living medicines" to people
• Hurdles and considerations when building a Good Manufacturing Practice (GMP) cellular facility

Do you have a question about development in the cell therapy space? Drop Back Bay a line.

Make sure to subscribe to our podcast and follow Back Bay Life Science Advisors on LinkedIn.

Thank you for joining us.